The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for Endoscopic Retrograde Cholangiopancreatography (ERCP) has exhibited robust growth in the past. The market size is projected to increase from $1.72 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 8.87%.
The projected market size of the endoscopic retrograde cholangiopancreatography (ERCP) market for 2029 is predicted to reach $2.60 billion with a compound annual growth rate (CAGR) of 8.58%.
Download Your Free Sample of the 2025 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Report and Uncover Key Trends Now!The key drivers in the endoscopic retrograde cholangiopancreatography (ercp) market are:
•Increasing prevalence of gastrointestinal conditions and cancer
•Heightened focus on investments, particularly in healthcare
•Rising demand for endoscopic equipment
•Infrastructure expansion within the healthcare sector and government healthcare.
The endoscopic retrograde cholangiopancreatography (ERCP) market covered in this report is segmented –
1) By Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices
2) By Disease Indication: Gastroesophageal Reflux Disease (GERD), Gastrointestinal Cancer, Barrett's Esophagus, Bile Duct Diseases, Peptic Ulcer Disease, Crohn's Disease, Intestinal Pseudo-Obstruction, Ogilvie Syndrome, Other Indications
3) By Application: Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, Pancreatic Duct Stentin
4) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users
Subsegments:
1) By Endoscopes: Flexible Endoscopes, Semi-Rigid Endoscopes, High-Resolution Endoscopes
2) By Endotherapy Devices: Stone Extraction Devices, Balloon Dilatation Catheters, Stents, Biopsy Forceps
3) By Visualization Systems: High-Definition Visualization Systems, Endoscopic Imaging Systems, Video Endoscopes
4) By Energy Devices: Electrosurgical Devices, Laser Devices, Argon Plasma Coagulation Systems
The key trends in the endoscopic retrograde cholangiopancreatography (ercp) market are:
•Technological advancements are expected to majorly influence the future of the ERCP market.
•There is a trend towards forming partnerships for research and development in this field.
•The expansion of the healthcare infrastructure globally is a significant emerging trend.
•The development of advanced products is an important trend shaping the future of the ERCP market.
Major players in the endoscopic retrograde cholangiopancreatography (ercp) market are:
• Medtronic plc
• Fujifilm Holdings Corporation
• Siemens Healthineers AG
• Stryker Corporation
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Olympus Corporation
• Ottomed Endoscopy
• W. L. Gore & Associates Inc.
• Streis plc
• Cook Group
• KARL STORZ SE & Co. KG
• CONMED Corporation
• PENTAX Medical Inc.
• AMBU Inc.
• Samsung Medison Co. Ltd.
• Medi-Globe GmbH
• Telemed System Inc.
• Micro-Tech Endoscopy Inc.
• Hobbs Medical Inc.
• Shaili Endoscopy Pvt. Ltd.
North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024